A smart watch is a consumer electronic until it makes a health claim. At that point it can become a regulated medical device, and the difference decides whether your order can be sold freely or needs clearance that takes months and costs more than the shipment.
In January 2026 the US regulator widened the range of what a wearable may measure while remaining a general wellness product. That change is the single most commercially significant development in this category this year, because it moves the boundary that Chinese suppliers have been guessing at for a decade.
This is the claim layer of the category. For the general certification file that applies to any electronic import, the marks, the issuers and how to verify them, our compliance guide covers that ground. For brand-line sourcing in the adjacent home category, including the Xiaomi ecosystem, the smart home wholesale guide deals with that. What follows is specific to wearables: where the health claim line runs, what the sensors can and cannot actually support, and what to put in a purchase order so a claim does not become a liability.
The Line That Moved in January 2026
The legal foundation predates this year, but the practical boundary shifted in January.
- · The statutory basis: section 3060(a) of the 21st Century Cures Act amended the US Food, Drug and Cosmetic Act in December 2016, removing certain software functions from the definition of a device
- · The operative wording: software intended for maintaining or encouraging a healthy lifestyle, and unrelated to the diagnosis, cure, mitigation, prevention or treatment of a disease or condition, is not a device
- · The guidance: the FDA's general wellness policy sets out how it exercises enforcement discretion for low risk products that promote a healthy lifestyle
- · What changed: in January 2026 the FDA updated its general wellness guidance, and reporting by legal and regulatory analysts indicates the revision widened the physiological parameters a non-invasive wearable may measure under enforcement discretion
- · The parameters reported as covered: blood pressure, blood oxygen saturation, blood glucose and heart rate variability, provided the output is presented for wellness rather than as a diagnosis
- · The condition attached: the discretion applies to products limited to general wellness use that present low risk, and legal commentators have stressed that the guardrails still matter
What General Wellness Means in Practice
- · A wellness product encourages healthy activity or tracks something without asserting a medical purpose
- · A medical device is intended for diagnosis, prevention, monitoring, treatment or alleviation of a disease
- · The distinction lives in the intended use, which is established by the labelling, the app copy, the marketing and the manual, not by the sensor
- · Practical consequence: the same hardware can sit on either side of the line depending on what you print on the box and write in the store listing
- · The task for a buyer: decide which side you want to be on before you approve artwork or app strings, because retrofitting a claim is more expensive than choosing one
What Pushes a Product Across the Line
The boundary is easier to see in examples than in definitions.
- · Stays on the consumer side: step counting, sleep duration, general activity tracking, and non-diagnostic heart rate shown as an estimate
- · Crosses the line: a feature that alerts the user to a condition, such as an irregular rhythm notification framed as a finding
- · Crosses the line: an ECG function presented as diagnostic, which is why cleared ECG features have gone through formal review rather than enforcement discretion
- · Crosses the line: blood pressure presented as a measurement rather than an estimate or a trend
- · The pattern to note: it is the alert and the diagnostic framing that trigger the obligation, not the underlying measurement
- · The referenced precedent: major brands have pursued formal clearance feature by feature for functions that touch disease, including an ECG app cleared in 2018, an irregular rhythm history feature cleared in 2022 and a sleep apnoea notification cleared in 2024
The Case That Defined the Current Position
- · A wearable brand received a warning letter over a blood pressure feature, which put the question squarely on the table
- · The FDA subsequently did not pursue enforcement over that feature, a decision widely read as reflecting the updated general wellness position
- · The takeaway for a sourcing buyer: the boundary is being enforced through discretion rather than through a bright statutory line
- · Why that matters commercially: discretion can narrow again, so a product strategy that depends only on the current reading of it carries policy risk
- · The prudent approach: document the intended use as wellness in the technical file, so the position is defensible if the reading changes
Europe Does Not Follow the Same Line
If you sell into the EU, the US analysis does not carry over.
- · The EU test is whether the manufacturer intends the device for a medical purpose, and the intended purpose is what the manufacturer declares
- · Monitoring heart rate, blood oxygen saturation and respiratory rate can fall within the medical device definition when the intended use is diagnosing or monitoring a physiological condition
- · That means a wearable sold as a wellness product in the US may still require conformity assessment as a medical device in the EU
- · A medical device route brings a quality management system obligation alongside the technical file, not just a test report
- · Practical implication: decide your market before you decide your feature set, because the stricter market sets the floor for the whole product
The Sensor Reality Behind the Spec Sheet
Most claims in this category are limited by physics rather than by supplier quality, and knowing the limits is what separates a defensible product from a refund queue.
- · The dominant sensor: optical photoplethysmography, which infers blood volume changes from light and is sensitive to motion
- · Where it struggles: during exercise, in cold conditions, and where perfusion is low, all of which are exactly when users want a reading
- · The consequence: heart rate is reliable at rest and degrades under motion, so an unrestrained accuracy claim is the fastest route to complaints
- · Why blood pressure from a wrist is contested: it is inferred rather than measured, and calibration is user-specific
- · What this means for your listing: describe the measurement as an estimate with stated conditions, and the product remains defensible
- · The quality lever: sensor module choice and the algorithms around it matter more than the display or the case, so specify the module rather than accepting whatever is fitted
What to Ask a Supplier About the Sensor
- · Which module is used, by manufacturer and part number, and whether that is fixed across production runs
- · How the heart rate algorithm performs under motion, and whether there is test data rather than a claim
- · Whether the temperature and skin tone conditions of that testing are stated
- · What the firmware update process is, and whether the accuracy can be improved after shipment
- · Whether the same firmware build ships to every market, or whether regional builds diverge
What Actually Differs Between Suppliers
At the component level this category is more standardised than it looks, which means the differentiation is elsewhere.
- · Displays: AMOLED panels dominate the mid and upper tiers, and the panel grade is a visible cost lever
- · Platforms: a handful of low power system on chip families are used across most products, so the chip rarely explains a price gap
- · The real variables: enclosure quality, band material, water resistance execution and firmware stability
- · Water resistance: an IP rating is a test condition, not a capability, so the depth and duration must be stated
- · Firmware: the most common complaint driver is not hardware failure but a companion app that stops syncing, so update policy belongs in the negotiation
- · Tooling: for a private label watch, the case and band tooling is the main non-recurring cost, and it is usually reusable for later runs
Battery, Band and Ingress Claims
Three specification areas account for a disproportionate share of returns, customs questions and listing takedowns.
- · Battery: wearables use small lithium polymer cells, and air transport rules for lithium batteries apply to them as they do to any other lithium product
- · The air transport constraint: lithium battery air shipments are subject to a state of charge limit, which affects how a supplier can dispatch sample and replenishment units
- · The documentation: a test summary for the cell and a compliant pack design are expected, and the supplier normally holds these rather than producing them on request
- · Band material: skin contact makes the band a compliance item, not an accessory, and nickel release and skin sensitisation are the usual concerns
- · Ingress claims: what a product survives in a lab test and what it survives in daily wear differ, so avoid amplifying a rating in marketing copy
- · The listing risk: an unqualified medical or durability claim is the most common cause of a marketplace takedown in this category
The Claim Discipline Checklist
- · Write the intended use first, before the feature list, and keep it wellness only unless you are pursuing clearance
- · Review every surface where claims appear: packaging, manual, store listing, app copy and support scripts
- · Remove verbs that assert diagnosis, detection or alerting unless the feature is cleared
- · State measurement conditions alongside any physiological figure you publish
- · Keep the technical file for the wellness position, so there is a documented basis for the intended use
- · Route features that touch disease through a compliance review before they reach production, not after
- · Align the EU and US positions before approving artwork, since one may need a stricter pathway
What to Specify in a Purchase Order
The specification document is where a wearables order is either secured or lost, because the claim position has to be translated into manufacturing instructions.
- · Sensor module: manufacturer and part number, with a requirement that substitutions are notified in writing
- · Firmware: version to be shipped, update mechanism and the language set required
- · Claim set: the exact wording permitted on packaging and in the app, and the wording that is prohibited
- · Battery: cell specification, documentation to be supplied and the state of charge at dispatch
- · Band: material specification and the skin contact standard to be met
- · Ingress: the specific test condition claimed, not just the rating level
- · Packaging and labelling: artwork approval gate, and which market's requirements it must satisfy
FAQ
Do I need FDA clearance to import smart watches from China
Not if the product is limited to general wellness use and presents low risk, which is the position the general wellness guidance covers. A feature that diagnoses, prevents or treats a disease moves the product into medical device territory and does require a clearance pathway.
Can a Chinese factory supply a blood pressure smart watch
It can supply the hardware, and blood pressure is among the parameters reported as covered by enforcement discretion when the output is presented for wellness rather than as a diagnosis. The obligation sits with the claim you make, not only with the sensor, so the intended use has to be settled before production.
Is an ECG feature on a smart watch a medical device
An ECG presented as diagnostic is treated as a medical device, which is why cleared ECG features have gone through formal review rather than enforcement discretion. Treat any ECG or rhythm alert feature as requiring a regulatory pathway before you commit to volume.
What should I check before approving packaging
Check every claim against the intended use, remove any diagnostic or alerting language, and require stated conditions for any physiological figure. Also confirm the market, because an EU sale may bring a stricter requirement than a US one.
Why do wearables get returned so often
The common causes are heart rate readings that degrade during motion, water resistance that was described more broadly than it was tested, and companion apps that stop syncing. All three are addressable in the specification rather than in the marketing.
Where This Leaves Your First Order
The commercial point of this category is that the regulatory position is decided long before the order is placed, in the wording of an intended use that most buyers never write down.
- · The sequence: choose the market, write the intended use, select the features, then specify the hardware
- · The trap: selecting features first and writing the claims afterwards, which is how an unimportable product gets tooled
- · The leverage: sensor module and firmware stability are specification items, so they can be contracted rather than hoped for
- · The risk to price in: clearance, if you decide a cleared feature is worth having, takes time and cost that a wellness product avoids
- · The category fit: our smart wearables range covers the product families this applies to, and the sourcing process behind them is described on our OEM and customisation service page
If a claim on your proposed packaging is the difference between an importable product and a delayed one, it is worth settling before tooling. Contact our team to review the intended use against the market you are selling into.